Argentina Nuclear Imaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The argentina nuclear imaging market size is expected to grow from USD 105.07 million in 2025 to USD 110.67 million in 2026 and is forecast to reach USD 143.45 million by 2031 at 5.33% CAGR over 2026-2031. This report is Segmented by Product (Equipment, Radioisotope [SPECT Radioisotopes: Technetium-99m, Thallium-201, Gallium, Iodine, Others; PET Radioisotopes: Fluorine-18, Rubidium-82, Others]), Application (Cardiology, Neurology, Thyroid, Oncology, Others), End User (Hospitals, Diagnostic Imaging Centres, and More). The Market Forecasts are Provided in Terms of Value (USD Million).

Argentina Nuclear Imaging Market Trends and Insights

Public Reimbursement Expansion for PET/CT Scans

The Programa Médico Obligatorio now covers PET/CT and gamma-camera oncology procedures without co-payments, removing a key affordability barrier and expanding access for lower-income populations. Procedure volumes in the Argentina nuclear imaging market are therefore rising at double-digit rates, particularly in provincial hospitals that previously limited advanced imaging due to budget constraints. The policy dovetails with national cancer initiatives that prioritize early detection and standardized follow-up protocols. Equipment utilization rates are climbing, prompting facilities to plan scanner upgrades within three years. Vendors offering flexible service contracts and remote diagnostics gain an edge because public hospitals must balance expanded demand with tight operating budgets.

Private-Sector Investment in Hybrid Imaging Centers

Currency-control reforms in late 2023 streamlined medical device imports, spurring private hospital groups to build dedicated PET/CT and SPECT/CT suites in major cities. These centers target affluent urban patients seeking concierge-style diagnostics and same-day reporting. Higher cash flows allow rapid adoption of AI reconstruction algorithms that cut scan times by up to 30%, lifting daily throughput. The Argentina nuclear imaging market thus benefits from a virtuous cycle of technology refresh and premium pricing. Domestic integrators such as INVAP partner with multinationals to supply turnkey facilities, embedding local support teams that mitigate peso volatility risks for investors.

Peso Volatility Raising Imported Device Prices

Roughly 80% of scanners and cyclotrons are sourced abroad and invoiced in U.S. dollars; sharp peso depreciation balloons procurement budgets and prompts payment-term renegotiations. Revised import rules now stagger settlement over four months, straining cash flow for public buyers. Some provincial tenders have been postponed, temporarily tempering the Argentina nuclear imaging market’s equipment refresh pace. Vendors mitigate risk by quoting in pesos at forward-hedged rates or offering operating leases that shift currency exposure onto manufacturers. Local assembly initiatives under discussion could offset volatility over the medium term.

Other drivers and restraints analyzed in the detailed report include:

• Growing Oncology Caseload and Precision-Medicine Shift
• Installation of Domestic Mo-99 Production Reactor (RA-10)
• Short Half-Life Isotope Logistics Outside Buenos Aires

Segment Analysis

Equipment accounted for 52.22% of the Argentina nuclear imaging market size in 2025, anchored by 389 SPECT and 42 PET scanners across public and private networks. Hospitals are cycling out first-generation gamma cameras, replacing them with SPECT/CT hybrids that support oncology staging and bone metastasis assessment. Vendors bundle five-year service contracts and AI upgrades, creating predictable cost structures that align with public-budget cycles. Local manufacturer INVAP supplies shielded hot cells and quality-control instruments, capturing niche demand and injecting domestic value into the supply chain.

Radioisotopes, though presently smaller in revenue terms, are forecast to grow at 5.56% CAGR as RA-10 brings molybdenum-99, lutetium-177, and iodine-131 production in-country. Domestic supply eliminates flight-dependent logistics for imported isotopes, lowering costs and spurring utilization, which feeds back into higher tracer demand. Contract manufacturing opportunities emerge for Dioxitek and Tecnonuclear to export surplus isotopes to Chile, Uruguay, and Paraguay. Consequently, the product mix will tilt gradually toward consumables, generating recurring revenue streams and broadening the Argentina nuclear imaging market.

Complete Report Scope:

• By Product
  • Equipment
  • Radioisotope
    • SPECT Radioisotopes
      • Technetium-99m (TC-99m)
      • Thallium-201 (TI-201)
      • Gallium (Ga-67)
      • Iodine (I-123)
      • Other SPECT Radioisotopes
    • PET Radioisotopes
      • Fluorine-18 (F-18)
      • Rubidium-82 (RB-82)
      • Other PET Radioisotopes
• By Application
  • Cardiology
  • Neurology
  • Thyroid
  • Oncology
  • Other Applications
• By End User (Value)
  • Hospitals
  • Diagnostic Imaging Centres
  • Academic & Research Institutes

List of Companies Covered in this Report:

• GE HealthCare Technologies Inc.
• Siemens Healthineers
• Koninklijke Philips
• Canon
• INVAP S.E.
• Dioxitek S.A.
• Curium Pharma
• Advanced Accelerator Applications S.A.
• Eckert & Ziegler AG
• Cardinal Health
• Dioxitek S.A.
• Tecnonuclear S.A.
• Cyclotek Argentina S.A.
• Laboratorios Bacon S.A.I.C.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support